+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
CorMedix Inc - logo

CorMedix is a commercial-stage pharmaceutical company focused on the treatment of infectious, inflammatory, and other serious diseases. The company markets Neutrolin, a catheter lock solution for the prevention of catheter related bloodstream infections. Neutrolin is approved as a CE Marked medical device in Europe where it was shown to reduce catheter-related bloodstream infections by 96% and thrombosis by 96.7%. Founded in 2006, it is based in Bridgewater, New Jersey.

Neuroblastoma (Oncology) - Drugs in Development, 2021 - Product Thumbnail Image

Neuroblastoma (Oncology) - Drugs in Development, 2021

  • Report
  • October 2021
  • 1265 Pages
From
Neuroblastoma - Pipeline Review, H2 2020 - Product Thumbnail Image

Neuroblastoma - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 1084 Pages
From
From
Osteosarcoma - Pipeline Review, H2 2020 - Product Thumbnail Image

Osteosarcoma - Pipeline Review, H2 2020

  • Drug Pipelines
  • August 2020
  • 868 Pages
From
From
Surgical Wound Infections - Pipeline Insight, 2020 - Product Thumbnail Image

Surgical Wound Infections - Pipeline Insight, 2020

  • Clinical Trials
  • February 2020
  • 106 Pages
From
From
From
CorMedix Inc (CRMD) - Product Pipeline Analysis, 2018 Update - Product Thumbnail Image

CorMedix Inc (CRMD) - Product Pipeline Analysis, 2018 Update

  • Company Profile
  • May 2018
  • 32 Pages
From
  • 12 Results (Page 1 of 1)
Loading Indicator